Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8.56M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
46.3M
-
Shares change
-
-104K
-
Total reported value, excl. options
-
$1.92B
-
Value change
-
-$3.17M
-
Put/Call ratio
-
1.95
-
Number of buys
-
55
-
Number of sells
-
-47
-
Price
-
$41.35
Significant Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q3 2018
147 filings reported holding ATRA - Atara Biotherapeutics, Inc. - Common Stock as of Q3 2018.
Atara Biotherapeutics, Inc. - Common Stock (ATRA) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.3M shares
.
Largest 10 shareholders include BAUPOST GROUP LLC/MA (6.25M shares), FMR LLC (5.18M shares), Redmile Group, LLC (4.22M shares), BlackRock Inc. (3.49M shares), Vanguard Group Inc (2.49M shares), BRIDGER MANAGEMENT, LLC (2.46M shares), STATE STREET CORP (2.11M shares), MORGAN STANLEY (1.89M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.77M shares), and EAGLE ASSET MANAGEMENT INC (1.62M shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.